AU673623B2 - Cosmetic compositions - Google Patents

Cosmetic compositions Download PDF

Info

Publication number
AU673623B2
AU673623B2 AU75206/94A AU7520694A AU673623B2 AU 673623 B2 AU673623 B2 AU 673623B2 AU 75206/94 A AU75206/94 A AU 75206/94A AU 7520694 A AU7520694 A AU 7520694A AU 673623 B2 AU673623 B2 AU 673623B2
Authority
AU
Australia
Prior art keywords
cosmetic composition
composition according
weight
document
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU75206/94A
Other versions
AU7520694A (en
Inventor
Gillian Scott Briggs
Teresa Barbara Crook
George Endel Deckner
Karen Fish
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU7520694A publication Critical patent/AU7520694A/en
Application granted granted Critical
Publication of AU673623B2 publication Critical patent/AU673623B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Description

I
WO 95/04537 PCT/US94/08838 COSMETIC COMPOSITIONS Field of the Invention The present invention relates to cosmetic compositions and more particularly, to pigmented foundation make-up compositions and concealers having anti-acne activity and formulation and colour stability.
Background of the Invention A foundation composition can be applied to the face and other parts of the body to even skin tone and texture and to hide pores, imperfections, fine lines and the like. A foundation composition is also applied to moisturize the skin, to balance the oil level of the skin and to provide protection against the adverse effects of sunlight, wind and the harsh environment.
Make-up compositions are generally available in the form of liquid or cream suspensions, emulsions, gels, pressed powders or anhydrous oil and wax compositions.
US Patent No. 3,444,291 discloses a method of filling and camouflaging skin cavities by applying a composition which includes to 75 parts by weight of a microcrystalline wax and about 25 to parts of a mineral oil. The composition includes a colourant, preferably a coal tar dye, for example, D &C Red No. 17, which matches the colour of the user's skin.
A spreadable, flowable and greaseless cosmetic cover-up composition is taught in US Patent No 4,486,405. That composition is characterized by the presence of a first and a second alkoxylated surfactant present in substantially the same concentration.
I r r LI WO 95/04537 PCT/US94/08838 US Patent No. 4,804,532 recites a facial cosmetic powder which utilizes crystalline silica in much lower concentration than that employed in the then prior art compositions. This powder, used as a blush or a facial coating, is said to be effective in hiding skin wrinkles, lines and pores. The composition is a mixture of a colour phase and a diluent phase. The colour phase is formed by blending crystalline silica with colourants. The resultant colour phase is mixed with the diluent phase, essentially formed from nacreous materials such as talc and mica, to form the composition.
The use of a foundation composition which has a significantly high concentration of nacreous material is taught in US Patent No.
3,978,207. This foundation, a pressed powder composition, is characterized by the presence of a nacreous material such as mica and a binder oil which provides a frosted pearl effect, that is, a lustrous look. The colour of this foundation is provided by the nacreous material.
US Patent No. 4,659,562 discloses a cosmetic make-up composition which includes, as a binding agent therefore, an intimate mixture of from 5 to 95 weight percent of a mixture of finely divided silica and about 5 to 95 weight percent of finely divided polyethylene fibres. The composition is recited to maintain its uniformity over the areas of the skin to which it is applied. That is, it is said to be "creaseproof". The composition of the '562 patent includes colourant in admixture with nacreous agents.
Nakamura et al., Preprints of the XIVth I.F.S.C.C. Congress, Barcelona, 1986, Vol. I, 51-63 (1986) describes a novel make-up composition utilizing spherical silica and polydimethyl siloxane. This combination is recited to provide a foundation which reduces wrinkle visibility to a greater extent than make-up foundations with which it was compared. This reduction in wrinkle visibility is caused by optical blurring enhanced by the novel use of spherical silica and polydimethyl siloxane.
WO 95/04537 PCT/US94/08838 3 US Patent No. 5,143,722 discloses a cosmetic make-up composition comprising water-in-oil emulsions comprising pigment coated with polysiloxane, a silicone phase, a water phase and a polydiorganosiloxane-polyoxyalkylene copolymeric surfactant.
Foundations in the form of water-in-oil emulsions are well known and provide good coverage and good skin feel, wear and appearance. At the same time, it would be desirable to provide a foundation composition having topical anti-acne activity. There are many compounds which are known to exhibit anti-acne properties when applied topically to the skin. A commonly used keratolytic agent having anti-acne activity is salicylic acid. As salicylic acid is virtually insoluble in water it is difficult to incorporate into the aqueous phase of an emulsion composition. Delivery of salicylic acid from the pigmentcontaining oil phase of an emulsion foundation composition can, however, lead to discolouration of the composition due to interaction between the salicylic acid and pigments, especially of the iron oxide type. It would therefore be desirable to deliver the salicylic acid in soluble form from the aqueous phase.
Polyvinylpyrrolidone is known for use as a solubilizing/complexing agent in a variety of compositions.
GB-A-2,041,963 discloses an aqueous detergent composition for cleansing oily skin comprising a water-soluble salt of an N-acyl ester of sarcosine, a polyvinylpyrrolidone cosolubilizer and a protein and/or protein hydrolysate. The composition can also contain salicylic acid as a keratolytic agent and a buffer such as citric acid/citrate. There is no disclosure, however, of cosmetic compositions containing solubilized acidic anti-acne actives in fully protonated form as specified herein.
Since acidic anti-acne agents are most active at low pH (when a high concentration of free acid is present in solution) it would be desirable to deliver the agent from an aqueous phase at a pH at which it exists significantly in protonated form. It is accordingly a primary object of this invention to provide a cosmetic composition comprising a low pH aqueous solution of an anti-acne active.
IWII~e~-~ ~I
I
WO 95/04537 PCT/US94/08838 4 It is also an object of the invention to provide a cosmetic composition having improved anti-acne activity and stability.
It is a further object of the invention to provide a cosmetic composition in the form of an oil-in-water or water-in-oil emulsion having improved colour stability and pigment/anti-acne active compatibility.
Summary of the invention In accordance with one aspect of the present invention, there is provided a cosmetic composition in the form of an emulsion, gel or lotion comprising an aqueous/alcoholic solution of an acidic anti-acne active and a pyrrolidone-based complexing agent therefor, and wherein the aqueous/alcoholic solution has a pH of less than about pKa 1, where pKa is the logarithmic acidity constant for the fully protonated anti-acne active.
The cosmetic compositions of the present invention provide anti-acne efficacy together with improved product and colour stability.
According to another aspect of the present invention there is provided a make-up composition in the form of a water-in-oil or oil-in-water emulsion comprising an acidic anti-acne active dissolved in the aqueous phase and a pigment or mixture of pigments dispersed in the oil phase.
All levels and ratios are by weight of total composition, unless otherwise indicated. Chain length and degrees of alkoxylation are also specified on a weight average basis.
Detailed Description of the Invention The cosmetic composition according to one aspect of the present invention comprises an aqueous/alcoholic solution of an acidic anti- WO 95/04537 PCT/US94/08838 acne active and a pyrrolidone-based complexing agent. The composition is in the form of an emulsion, gel or lotion.
According to this first aspect of the present invention a first essential component is an aqueous/alcoholic solution of an anti-acne active.
Suitable anti-acne actives for use herein include salicylic acid, retinoic acid and its derivatives, azelaic acid and its derivatives, lactic acid, glycolic acid, pyruvic acid, flavonoids, and mixtures thereof.
The anti-acne active used in the composition herein is preferably selected from salicylic acid and azelaic acid, and mixtures thereof, more preferably salicyclic acid. The anti-acne active is present at a level of from about 0.1% to about 10%, preferably from about 0.1% to about more preferably from about 0.5% to about by weight of composition.
The anti-acne active is solubilized in water or an alcoholic solution, for example, solutions based upon C 2 -C6 alcohols, diols and polyols, preferred alcohols being selected from ethanol, dipropylene glycol, butylene glycol, hexylene glycol, and mixtures thereof. Alcohol is preferably present in the compositions herein at a level of from about 1% to about 20%. The final aqueous/alcoholic anti-acne active solution preferably has a pH at ambient temperature (25 of less than about pKa 1, where pKa is the logarithmic acidity constant for the fully protonated anti-acne active. In preferred embodiments, the pH of the final solution is less than about pKa.
The logarithmic acidity constant is thus defined by reference to the equilibrium H+ Hn-_A HnA where HnA is the fully protonated acid, n is the number of protons in the fully protonated acid and Hn- 1 A is the conjugate base of the acid corresponding to loss of one proton.
-e L I L I II- I_ WO 95/04537 PCT/US94/08838 6 The acidity constant for this equilibrium is therefore Kn [HnA] [H [Hn-IA] and pKa logl0K For the purposes of this specification, acidity constants are defined at 0 C and at zero ionic strength. Literature values are taken where possible (see Stability Constants of Metal-Ion Complexes, Special Publication No. 25, The Chemical Society, London); where doubt arises they are determined by potentiometric titration using a glass electrode.
The pKa of the acidic anti-acne active used herein is preferably in the range of from about 1 to about 6, more preferably from about 1 to about 4.5, especially from about 1.5 to about The pH of the final aqueous/alcoholic anti-acne active solution is preferably in the range of from about 1 to about 7, more preferably from about 2 to about 5, especially from about 2 to about 4. At pH values of less than about 5 the aqueous phase is preferably free of acid labile species such as acrylic acid/ethyl acrylate copolymers and polyglycerylmethacrylate.
A second essential component of the compositions of the first aspect of the present invention is a pyrrolidone-based complexing agent.
The pyrrolidone-based complexing agent is useful herein from the viewpoint of aiding solubilization of the anti-acne active. The pyrrolidone-based complexing agent used herein is preferably selected from polyvinylpyrrolidone complexing agents or C1-C4 alkyl polyvinylpyrrolidone complexing agents having a molecular weight (viscosity average) in the range from about 1500 to about 1,500,000, preferably from about 3000 to about 700,000, more preferably from about 5000 to about 100,000. Suitable examples of pyrrolidone-based r I_ WO 95/04537 PCT/US94/08838 7 complexing agents are polyvinylpyrrolidone (PVP) (or povidone) and butylated polyvinylpyrrolidone. The most preferred pyrrolidone-based complexing agent herein is a polyvinylpyrrolidone complexing agent.
PVP is commercially available under the trade name Luviskol (RTM) from BASF. A preferred PVP complexing agent herein is Luviskol K17 which has a viscosity-average molecular weight of about 9,000.
Other pyrrolidone-based complexing agents for use herein include CI-
C
1 S alkyl or hydroxyalkyl pyrrolidones such as lauryl pyrrolidone.
The pyrrolidone-based complexing agent is present in the composition herein in a level of from about 0.1 to about 10%, preferably from about 0.1% to about 5% by weight of composition. The weight ratio of anti-acne active pyrrolidone-based complexing agent is in the range from about 10:1 to about 1:10, preferably from about 5:1 to about Preferred embodiments of the invention additionally comprise from about 0.01% to about 5% by weight of an acid or salt thereof which is soluble in water at pH values of less than or equal to the pKa of the corresponding acid, for example, an acid selected from citric acid, boric acid, and salts, and mixtures thereof. These materials are valuable herein in combination with the pyrrolidone-based complexing agent from the viewpoint of aiding solubilization of the anti-acne active. Particularly preferred herein from this viewpoint is a sodium salt of citric acid. In preferred embodiments, the acid or salt thereof is soluble to a level of at least 5% w/w at 25 0
C.
The composition of the present invention can be in emulsion (w/o or gel or lotion form but is preferably in the form of a water-in-oil emulsion, wherein in preferred embodiments the oil phase comprises a mixture of volatile silicones and non-volatile silicones. The silicone oil is present in an amount of from about 1 to about 50% by weight.
Suitable volatile silicone oils include cyclic and linear volatile polyorganosiloxanes (as used herein, "volatile" refers to those materials which have a measurable vapour pressure at ambient conditions).
is 1 F I I L I I I i I I I-- WO 95/04537 PCT/US94/08838 8 A description of various volatile silicones is found in Todd, et al..
"Volatile Silicone Fluids for Cosmetics", 91 Cosmetics and Toiletries 27-32 (1976).
Preferred cyclic silicones include polydimethylsiloxanes containing from about 3 to about 9 silicon atoms, preferably containing from about 4 to about 5 silicon atoms. Preferred linear silicone oils include the polydimethylsiloxanes containing from about 3 to about 9 silicon atoms. The linear volatile silicones generally have viscosities of less than about 5 centistokes at 25°C, while the cyclic materials have viscosities of less than about 10 centistokes. Examples of silicone oils useful in the present invention include: Dow Corning 344, Dow Corning 21330, Dow Corning 345, and Dow Corning 200 (manufactured by the Dow Corning Corporation): Silicone 7207 and Silicone 7158 (manufactured by the Union Carbide Corporation).
SF:202 (manufactured by General Electric) and SWS-03314 (manufactured by Stauffer Chemical).
Suitable non-volatile silicones preferably have an average viscosity of from about 1,000 to about 2,000,000 mm 2 .s- 1 at 25°C. more preferably from about 10,000 to about 1,800,000 mm 2 .s 1 even more preferably from about 100,000 to about 1,500,000 mm 2 .s- 1 Lower viscosity non-volatile silicone conditioning agents, however, can also be used. Viscosity can be measured by means of a glass capillary viscometer as set forth in Dow Corning Corporate Test Method CTM0004, July 20, 1970. Suitable non-volatile silicone fluids for use herein include polyalkyl siloxanes, polyaryl siloxanes, polyalkylaryl siloxanes, polysiloxanes with amino functional substitutions, polyether siloxane copolymers, and mixtures thereof. The siloxanes useful in the present invention may be endcapped with any number of moieties, including, for example, methyl, hydroxyl, ethylene oxide, propylene oxide, amino and carboxyl. However, other silicone fluids having skin conditioning properties may be used. Th.a non-volatile polyalkyl siloxane fluids that may be used include, for example, polydimethylsiloxanes. These siloxanes are available, for example, from the General Electric Company as a Viscasil (RTM) series and from Dow Corning as the Dow Corning 200 series. Preferably, the p- i-ra ~lr~ P L I WO 95/04537 PCT/US94/08838 9 viscosity ranges from about 10 mm 2 .s- 1 to about 100,000 mm 2 .s 1 at 0 C. The polyalkylaryl siloxane fluids that may be used, also include, for example, polymethylphenylsiloxanes. These siloxanes are available, for example, from the General Electric Company as SF 1075 methyl phenyl fluid or from Dow Corning as 556 Cosmetic Grade Fluid. The polyether siloxane copolymer that may be used includes, for example, a polypropylene oxide modified dimethylpolysiloxane Dow Corning DC-1248) although ethylene oxide or mixtures of ethylene oxide and propylene oxide may also be used.
References disclosing suitable silicone fluids include US-A-2,826,551, Green; US-A-3,964,500, Drakoff, issued June 22nd, 1976; US-A- 4,364,837, Pader; and GB-A-849,433, Woolston. In addition, Silicone Compounds distributed by Petrarch Systems Inc., 1984 provides an extensive (though not exclusive) listing of suitable silicone fluids.
Preferred non-volatile silicones for use herein include polydiorganosiloxane-polyoxyalkylene copolymers containing at least one polydiorganosiloxane segment and at least one polyoxyalkylene segment, said polydiorganosiloxane segment consisting essentially of RbSiO(4-b)/2 siloxane units wherein b has a value of from about 0 to about 3, inclusive, there being an average value of approximately 2 R radicals per silicon for all siloxane units in the copolymer, and R denotes a radical selected from methyl, ethyl, vinyl, phenyl and a divalent radical bonding said polyoxyalkylene segment to the polydiorganosiloxane segment, at least about 95% of all R radicals being methyl; and said polyoxyalkylene segment having an average molecular weight of at least about 1000 and consisting of from about 0 to about 50 mol percent polyoxypropylene units and from about 50 to about 100 mol percent polyoxyethylene units, at least one terminal portion of said polyoxyalkylene segment being bonded to said slp~-p 9 11 I WO 95/04537 PCT/US94/08838 polydiorganosiloxane segment, any terminal portion of said polyoxyalkylene segment not bonded to said polydiorganosiloxane segment being satisfied by a terminating radical; the weight ratio of polydiorganosiloxane segments to polyoxyalkylene segments in said copolymer having a value of from about 2 to about 8. Such polymers are described in US-A-4,268,499.
More preferred for use ?ein are polydiorganosiloxanepolyoxyalkylene copolym, ,aving the general formula:
CH
3
CH
3 CH 3 CH3
H
3 C Si (Si- O) -Si- CH 3 x y
CH
3
CH
3
C
3
H
6
CH
3 0 (C2H 4 0)a(C 3 wherein x and y are selected such that the weight ratio of polydiorganosiloxane segments to polyoxalkylene segments is from about 2 to about 8, the mol ratio of is from about 0.5 to about 1, and R is a chain terminating group, especially selected from hydrogen; hydroxyl; alkyl, such as methyl, ethyl, propyl, butyl, benzyl; aryl, such as phenyl; alkoxy such as methoxy, ethoxy, propoxy, butoxy; benzyloxy; aryloxy, such as phenoxy; alkenyloxy, such as vinyloxy and allyloxy; acyloxy, such as acetoxy, acryloxy and propionoxy and amino, such as dimethylamino.
The number of and average molecular weights of the segments in the copolymer are such that the weight ratio of polydiorganosiloxane segments to polyoxyalkylene segments in the copolymer is preferably from about 2.5 to about ra~sl- R~ I C WO 95/01453' PCT/US94/08838 11 Suitable copolymers are available commercially under the tradenames Belsil (RTM) from Wacker-Chemie GmbH, Geschaftsbereich S, Postfach D-8000 Munich 22 and Abil (RTM) from Th. Goldschmidt Ltd,. Tego House, Victoria Road, Ruislip, Middlesex, HA4 OYL.
Particularly preferred for use herein are Belsil (RTM) 6031, Abil (RTM) B88183 and DC3225C. A preferred silicone herein is known by its CTFA designation as dimethicone copolyol.
The silicone oil phase preferably comprises from about 2% to about more preferably from about 5% to about 15 by weight of composition of non-volatile silicones.
A highly preferred component of the compositions herein is a humectant or mixture of humectants. The humectant or mixture of humectants herein is present in an amount of from about 0.1 to about preferably from about 5% to about 25 and more preferably from about 10% to about 20% by weight of composition. Suitable humectants are selected from glycerine and polyglycerylmethacrylate lubricant having a viscosity at 25°C of 300,000 to 1,100,000 cps; a specific gravity at 25°C of 1 to 1.2g/ml, a pH of 5.0 to 5.5; a bound water content of 33 to 58%; and, a free water content from 5 to The humectant can be incorporated at least partly into the oil phase of the water-in-oil emulsion so as to form a multiphase humectant-in-oilin-water dispersion. The oil phase preferably comprises from about 0.1% to about 10%, more preferably from about 0.1% to about 3% by weight of humectant on a composition basis. The humectant can be introduced into the oil phase in the form of a mixture with or incorporated within a particulate lipophilic or hydrophobic carrier material.
Polyglycerylmethacrylate lubricants having the desired properties are marketed by Guardian Chemical Corporation under the trademark "Lubrajel". The "Lubrajels" identified as "Lubrajel DV", "Lubrajel MS", and "Lubrajel CG" are preferred in the present invention. The gelling agents sold under these trademarks contain about I propylene glycol.
~-rls~ss I -,r-sa I c IIL-- WO 95/04537 PCT/US94/08838 12 Other suitable humectants inctude sorbitol, panthenols, prop"lene glycol, butylene glycol, hexylene glycol, alkoxylated glucose derivatives, such as Glucam (RTM) E-20, hexanetriol, and glucose ethers, and mixtures thereof. Urea is also suitably added as a humectant in the internal aqueous phase.
The panthenol moisturiser can be selected from D-panthenol dihydroxy-N-[3-hydroxypropyl)]-3,3-dimethylbutamide),
DL-
panthenol, calcium pantothenate, royal jelly, panthetine, pantotheine, panthenyl ethyl ether, pangamic acid, pyridoxin, pantoyl lactose and Vitamin B complex.
The preferred humectant herein is glycerine. Chemically, glycerine is 1,2,3-propanetriol and is a product of commerce.
Preferred embodiments herein comprise a pigment )r mixture of pigments. Suitable pigments for use herein can Iw iorganic and/or organic. Also included within the term pigment are materials having a low colo 'r or lustre such as matte finishing agents, and also light scattering agents. Examples of suitable pigments are iron oxides, acylglutamate iron oxides, ultramarine blue, D&C dyes, carmine, and mixtures thereof. Depending ipon the type of make-up composition, eg. foundation or blusher, a mixture of pigments will normally be used.
It is a feature of the composition herein that the pigment and anti-acne active have excellent overall compatability and colour stability. Thus according to another aspect of the present invention there is provided a make-up composition in the form of a water-in-oil or oil-in-water emulsion comprising an acidic anti-acne active dissolved in the aqueous phase and a pigmern or mixture of pigments dispersed in the oil phase.
The foundation composition can also include at least one matte finishing agent. The function of the matte finishing agent is to hide skin defects and reduce shine. Such cosmetically acceptable inorganic Ii~seA~B~- le~-~ue~~ I I~ I WO 95/04537 PCT/US94/08838 13 agents, those included in the CTFA Cosmetic Ingredient Dictionary, Third Ed., as silica, hydrated silica, silicone-treated silica beads, mica, talc, polyethylene, titanium dioxide, bentonite, hectorite, kaolin, chalk, diatomaceous earth, attapulgite zinc oxide and the like may be utilized. Of particular usefulness as a matte finishing agent is low lustre pigment such as titanated mica (mica coated with titanium dioxide) coated with barium sulfate. Of the inorganic components useful as a matte finishing agent low lustre pigment, talc, polyethylene, hydrated silica, kaolin, titanium dioxide and mixtures thereof are particularly preferred. Materials suitable for use herein as lightscattering agents cai, be generally described as spherical shaped inorganic materials having a particle size of up to about 100 microns, preferably From about 5 to about 50 microns, for example spherical silica particles.
The total concentration of the pigment may be from about 0. 1 to about by weight and is preferably from about 1 to about 10% by weight of the total composition, the exact concentration being dependent to some extent upon the specific mixture of pigments selected for use in a foundation make-up or blusher to achieve the desired shades. The preferred compositions contain from about 2% to about 20% by weight of titanium dioxide and most preferably from about 5 to about by weight of titanium dioxide.
The preferred pigments for use herein from the viewpoint of moisturisation, skin feel, skin appearance and emulsion compatibility are treated pigments. The pigments can be treated with compounds such as amino acids such as lysine, silicones, lauroyl, collagen, polyethylene, lecithin and ester oils. The more preferred pigments are the silicone (polysiloxane) treated pigments.
The balance of the composition of the present invention is deionized water. The composition preferably comprises from about 30% to about 95%, more preferably from about 40% to about 80% by weight of the oil phase, and from about 5% to about 70%, more preferably from about 20% to about 60% by weight of the water phase.
L 1 I I I WO 95/04537 PCT/US94/08838 14 The make-up compositions of the present invention can also comprise a particulate cross-linked hydrophobic acrylate or methacrylate copolymer. This copolymer is particularly valuable for reducing shine and controlling oil while helping to provide effective moisturization benefits. The cross-linked hydrophobic polymer is preferably in the form of a copolymer lattice with at least one active ingredient dispersed uniformly throughout and entrapped within the copolymer lattice. Alternatively, the hydrophobic polymer can take the form of a porous particle having a surface area (N2-BET) in the range from about 50 to 500, preferably 100 to 300m 2 /g and having the active ingredient absorbed therein.
The cross-linked hydrophobic polymer when used herein is in an amount of from about 0.1 to about 10% by weight and is preferably incorporated in the external silicone-containing oil phase. The active ingredient can be one or more or a mixture of skin compatible oils, skin compatible humectants, emollients, moisturizing agents and sunscreens. The polymer material is in the form of a powder, the powder being a combined system of particles. The system of powder particles forms a lattice which includes unit particles of less than about one micron in average diameter, agglomerates of fused unit particles of sized in the range of about 20 to 100 microns in average diameter and aggregates of clusters of fused agglomerates of sizes in the range of about 200 to 1,200 microns in average diameter.
The powder material of the present invention which can be employed as the carrier for the active ingredient can be broadly described as a cross-linked "post absorbed" hydrophobic polymer lattice. The powder preferably has entrapped and dispersed therein, an active which may be in the form of a solid, liquid or gas. The lattice is in particulate form and constitutes free flowing discrete solid particles when loaded with the active material. The lattice may contain a predetermined quantity of the active material. The polymer has the structural formula: Iraaer c F~
I~
WO 95/04537 PCT/US94/08838
CH
3 CH3 CHy- C C CH 2
C=O
0
C=O
0 R'
C=O
CH-- C C3
X
where the ratio of x to (CH2)11CH3.
y is 80:20, R' is -CH2CH2- and R" is The hydrophobic polymer is a highly crosslinked polymer, more particularly a highly cross-linked polymethacrylate copolymer. The material is manufactured by the Dow Corning Corporation, Midland.
Michigan, USA, and sold under the trademark POLYTRAP (RTM) It is an ultralight free.flowing white powder and the particles are capable of absorbing high levels of lipophilic liquids and some hydrophilic liquids while at the same time maintaining a free-flowing powder character. The powder structure consists of a lattice of unit particles less than one micron that are fused into agglomerates of 20 to 100 microns and the agglomerates are loosely clustered into macroparticles or aggregates of about 200 to about 1200 micron size. The polymer powder is capable of containing as much as four times its weight of fluids, emulsions, dispersions or melted solids.
Iglpplpgp l I~ -I WO 95/04537 IPCT/US94/08838 16 Adsorption of actives onto the polymer powder can be accomplished using a stainless steel mixing bowl and a spoon, wherein the active is added to the powder and the spoon is used to gently fold the active into the polymer powder. Low viscosity fluids may be adsorbed by addition of the fluids to a sealable vessel containing the polymer and then tumbling the materials until a consistency is achieved. More elaborate blending equipment such as ribbon or twin cone blenders can also be employed. The preferred active ingredient for use herein is glycerine. Preferably, the weight ratio of humectant carrier is from about 1:4 to about 3:1.
Also suitable as a highly cross-linked polymethacrylate copolymer is Microsponges 5647. This takes the form of generally spherical particles of cross-linked hydrophobic polymer having a pore size of from about 0.01 to about 0.05Arm and a surface area of 200-300m 2 /g.
Again, it is preferably loaded with humectant in the levels described above.
The compositions of the invention can also contain a hydrophilic gelling agent at a level preferably from about 0.01% to about more preferably from about 0.02% to about and especially from about 0.02% to about The gelling agent preferably has a viscosity aqueous solution, 20 0 C, Brookfield RVT) of at least about 4000 mPa.s, more preferably at least about 10,000 mPa.s and especially at least 50,000 mPa.s.
Suitable hydrophilic gelling agents can generally be described as water-soluble or colloidally water-soluble polymers, and include cellulose ethers hydroxyethyl cellulose, methyl cellulose, hydroxypropylmethyl cellulose), polyvinylalcohol, guar gum, hydroxypropyl guar gum and xanthan gum.
Among suitable hydrophilic gelling agents are acrylic acid/ethyl acrylate copolymers and the carboxyvinyl polymers sold by the B.F.
Goodrich Company under the trade mark of Carbopol resins. These resins consist essentially of a colloidally water-soluble polyalkenyl polyether crossiinked polymer of acrylic acid crosslinked with from P1I1 e -I I WO 95/04537 PCT/US94/08838 17 0.75% to 2.00% of a crosslinking agent such as for example polyallyl sucrose or polyallyl pentaerythritol. Examples include Carbopol 934, Carbopol 940, Carbopol 950, Carbopol 980, Carbopol 951 and Carbopol 981. Carbopol 934 is a water-soluble polymer of acrylic acid crosslinked with about 1% of a polyallyl ether of sucrose having an average of about 5.8 allyl groups for each sucrose molecule. Also suitable for use herein are hydrophobically-modified cross-linked polymers of acrylic acid having amphipathic properties available under the Trade Name Carbopol 1382, Carbopol 1342 and Pemulen TR-I (CTFA Designation: Acrylates/10-30 Alkyl Acrylate Crosspolymer).
A combination of the polyalkenyl polyether cross-linked acrylic acid polymer and the hydrophobically modified cross-linked acrylic acid polymer is also suitable for use herein. Other suitable gelling agents suitable for use herein are oleogels such as trihydroxystearin and aluminium magnesium hydroxy stearate. The gelling agents herein are particularly valuable for providing excellent stability characteristics over both normal and elevated temperatures.
Neutralizing agents suitable for use in neutralizing acidic group containing hydrophilic gelling agents herein include sodium hydroxide, potassium hydroxide, ammonium hydroxide, monoethanolamine, diethanolamine and triethanolamine.
The make-up compositions herein can additionally comprise an emollient. Emollients suitable for the compositions of the present invention include natural and synthetic oils selected from mineral, vegetable, and animal oils, fats and waxes, fatty acid esters, fatty alcohols, alkylene glycol and polyalkylene glycol ethers and esters, fatty acids and mixtures thereof.
Suitable emollients for use herein include, for example, optionally hydroxy-substituted C8-C50 unsaturated fatty acids and esters thereof, C1-C24 esters of C8-C30 saturated fatty acids such as isopropyl myristate, cetyl palmitate and octyldodecylmyristate (Wickenol 142), beeswax, saturated and unsaturated fatty alcohols such as behenyl alcohol and cetyl alcohol, hydrocarbons such as mineral oils, petrolatum and squalane, fatty sorbitan esters (see US-A-3988255, IsP~ 1-r- I I -r I WO 95/04537 PCT/US94/08838 18 Seiden, issued October 26 1976), lanolin and lanolin derivatives, such as lanolin alcohol ethoxylated, hydroxylated and acetylated lanolins, cholesterol and derivatives thereof, animal and vegetable triglycerides such as almond oil, peanut oil, wheat germ oil, linseed oil, jojoba oil, oil of apricot pits, walnuts, palm nuts, pistachio nuts, sesame seeds, rapeseed, cade oil, corn oil, peach pit oil, poppyseed oil, pine oil, castor oil, soybean oil, avocado oil, safflower oil, coconut oil, hazelnut oil, olive oil, grapeseed oil, and sunflower seed oil and C 1
-C
24 esters of dimer and trimer acids such as diisopropyl dimerate, diisostearylmalate, diisostearyldimerate and triisostearyltrimerate.
Preferred emollients are selected from hydrocarbons such as isohexadecane, mineral oils, petrolatum and squalane, lanolin alcohol, and stearyl alcohol. These emollients may be used independently or in mixtures and may be present in the composition of the present invention in an amount from about 1% to about 30% by weight, and preferably are present in an amount from about 5 to about 15 by weight of the total composition.
The composition may also contain additional materials such as, for example, fragrances, fillers such as nylon, sun-screens, preservatives, electrolytes such as sodium chloride, proteins, antioxidants, chelating agents and water-in-oil emulsifiers as appropriate.
Another optional component of the make-up composition is one or more ultraviolet absorbing agents. Ultraviolet absorbing agents, often described as sunscreening agents, can be present in a concentration in the range of between about 1% and about 12% by weight, based on the total weight of composition. Preferably, the UV absorbing agents constitute between about 2% and 8% by weight. More preferably, the UV absorbing agents can be present in the composition in a concentration range of between about 4% and about 6% by weight. Of the ultraviolet absorbing agents suitable for use herein, benzophenone- 3, octyl dimethyl PABA (Padimate 0) and mixtures thereof are particularly preferred.
ssr=~ rllPmllP1I I L-- I L WO 95/04537 PCT/US94/08838 19 Another optional but preferred component herein is one or more additional chelating agents, preferably in the range of from about 0.02% to about 0.10% by weight, based on the total weight of the composition. Preferably, the chelating agent is present in a concentration in the range of between about 0.03 and about 0.07 by weight, based on the total weight of the composition. Among the chelating agents that may be included in the composition is tetrasodium
EDTA.
Another optional but preferred component of the foundation composition is one or more preservatives. The preservative concentration in the foundation composition, based on the total weight of that composition, is in the range of between about 0.05 and about 0.8% by weight, preferably between about 0.1 and about 0.3% by weight. Suitable preservatives for use herein include sodium benzoate and propyl paraben, and mixtures thereof.
The make-up compositions of the present invention can be in the form of foundations, blushers, concealers, compact powders, and the like, preferably as foundations and concealers.
m.aP~p~- ~r I -Y I II I WO 95/04537 PCT/US94/08838 The following Table is provided up of the present invention: to illustrate compositions of the make- Example
A.
Cetyloctanoate Cyclomethicone Cyclomethicone/ dimethicone copolyol (90:10) Propylparaben in laureth-7 Dimethicone Fluid Benzophenene-3 Propylene glycol Dicaprylate/ Dicaprate
B.
Titanium Dioxide Titanium Dioxide treated (Aluminium hydrate, stearic acid) Titanated Micas Talc Silica Nylon 2.00 8.57 17.16 0.75
II
Wt 0.0 12.25 20.0 0.75
III
Wt 0.0 12.25 20.0 0.0
IV
Wt 0.0 15.0 5.0 0.75
V
Wt 0.0 12.0
VI
Wt 0.0 8.57
VII
Wt 8.57 17.16 0.75 8.0 10.0 0.0 0.75 2.0 0.0 2.0 3.0 5.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 5.0 0.0 10.0 0.0 8.25 6.0 1.5 6.0 8.0 20.0 8.25 0.25 0.1 3.38 0.6 0.0 0.5 0.1 4.5 4.25 0.0 3.0 0.1 6.0 6.0 0.0 0.25 0.25 0.7 4.25 0.0 0.25 1.0 0.7 0.6 0.5 0.25 0.1 3.38 0.6 0.0 I~~ONOREMENWEWOIWJ I- I I I I 9 1 WO 95/04537 PCT/US94/08838 Example VII Wt
C.
Cyclomethicone/ dimethicone copolyol (90:10)
D.
Yellow Iron Oxide Red Iron Oxide Black Iron Oxide Ultramarine Blue Cyclomethicone
E.
Synthetic Wax Arachidyl behenate Stearic Acid Palmitic Acid Silica (spheron P1500)
F.
Trihydroxystearin Cyclomethicone Beeswax Abil WED9 1.85 1.5 1.85 5.0 1.0 1.0 1.85 1.2 0.49 0.16 0.0 0.0 0.6 0.6 0.24 0.0 0.0 0.4 0.49 0.1 0.1 0.0 1.2 0.49 0.1 0.0 0.68 1.2 0.2 0.24 0.0 0.0 1.2 0.6 0.24 0.0 0.0 0.1 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.3 0.0 0.0 0.0 0.3 0.0 2.5 0.0 0.3 0.0 0.0 0.3 0.3 1.5 1.5 0.0 0.0 0.0 4.0 1.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19C PIPPB~~ e ~os~es 1 -1 -L I I WO 95/04537 PCT/US94/08838 Example 22 I II III IV V VI VII Wt Wt Wt Wt Wt Wt Wt 0.05 0.0 0.0 0.0 0.0 0.05 0.05 0.05 0.0 0.0 0.0 0.0 0.05 0.05
G.
Ethylene brassylate
BHT
Deionized water Ethanol Salicylic acid Azeleic acid Propylene glycol Dipropylene glycol Sodium chloride Glycerine Tetrasodium
EDTA
Triethanolamine Allantoin sunscreen polyvinylpyrrolid- -one (Luviskol K17) Sodium citrate Sodium Tetraborate pH of aqueous phase
I.
Deionized Water 6 1 0.0 2.37 6.0 0.5 4.5 0.05 5.5 1 0.0 2.37 5.0 0.5 5.0 0.05 to 4.0 1 0.0 1.37 6.5 0.5 10.0 0.05 100-- 7 2 0.0 2.37 7.00 0.5 5.0 0.1 6.0 2 0.0 0.0 8.0 0.5 5.0 0.1 8.0 2 0.0 2.37 6.0 0.5 10.0 0.1 0.0 0.0 15.0 0.01 0.75 0.0 0.0 2 0.0 0.0 0.0 1 0.0 0.0 0.0 2 0.0 0.1 0.0 1.5 0.0 0.0 0.2 1.
0.0 0.0 0.2 1 0.0 0.0 0.0
I
0.3 0.3 0.0 0.2 0.4 0.3 0.4 0.0 0.0 0.1 0.4 0.0 0.2 0.0 2.9 2.8 2.9 3.2 3.0 2.9 3.1 0.0 0.0 0.0 0.0 10.0 0.0 0.0 C L- WO 95/04537 PCT/US94/08838 Example Propylene Glycol Xanthan Gum
K.
Essential Oils Perfume Oil Vitamin A Palmitate 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.08 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.25 0.0 0.20 0.0 0.20 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.05 0.0 0.0 0.0 0.0 0.0 Aloe Vera Gel Chamomile Extract 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0,1 0.0 0.0 0.0 0.0 Contains about 1% propylene glycol.
The various components listed in the Table have been segregated into groups, the constituents of each group being mixed together before being added to members of the remaining groups in accordance with the procedures set forth below.
In the first step, the mixture of components of phase A is stirred for approximately 5 minutes with sheer mixing until homogeneous. With high speed sheer mixing, the materials of phase B are added gradually to A and the batch is mixed for 20 minutes until dispersed.
The components of phase C and then phase D are slowly added to the mixture of phases A and B with high shear mixing until dispersed.
Silica is added at this point and dispersed through the mixture.
BL~P1 IC1~' I 'I-r I I I It.r -1 w 4 A l:Il WO 95/04537 PCT/US94/08838 24 The resulting batch heated to 90 0 C before the addition of the components of phase E, The vessel is cooled to 55°C and the premixed phase F is added. The batch is mixed until homogeneous.
The mixture is cooled to 30 0 C and phase G is added.
A premix of phase H is made by mixing all the components until completely dissolved. At 30 0 C the premix of phase H is added to the batch mixture with high shear, ensuring that there is no excess water on the surface. The mixture is then milled for 15 minutes.
Finally phases I, J, K, and L are added as diluent.
The resulting make-up composition is ready for packaging.
The make-up compositions of the Examples exhibit anti-acne activity and improved formulation and colour stability.
81 I~CBlr-~s ~n

Claims (28)

1. A cosmetic composition in the form of an emulsion, gel or lotion comprising an aqueous/alcoholic solution of an anti-acne active and a pyrrolidone-based complexing agent therefor, and wherein the aqueous/alcoholic solution has a pH of less than pKa 1, where pKa is the logarithmic acidity constant for the fully protonated anti-acne active.
2. A cosmetic composition according to Claim 1 comprising from 0.1% to by weight of anti-acne active.
3. A cosmetic composition according to Claim 1 comprising from 0.1% to by weight of pyrrolidone-based complexing agent.
4. A cosmetic composition according to Claim 3 wherein the pyrrolidone-based complexing agent is selected from a polyvinylpyrrolidone complexing agent.
5. A cosmetic composition according to any of Claims 1 to 4 wherein the anti-acne active is selected from salicylic acid, retinoic acid and its derivatives, azelaic acid and its derivatives, lactic acid, glycolic acid, pyruvic acid, flavonoids, and mixtures thereof.
6. A cosmetic composition according to Claim 5 wherein said anti-acne active is selected from salicylic acid and azelaic acid and mixtures thereof.
7. A cosmetic composition according to any of Claims 1 to 6 additionally comprising from 0.01% to 5% by weight of citric acid or salt thereof.
8. A cosmetic composition according to any of Claims 1 to 7 in the form of a water-in-oil emulsion. W I- I ~ba r ~L1 1 26
9. A cosmetic composition according to Claim 8 comprising from 1% to by weight of silicone oil selected from volatile silicones, non-volatile silicones and mixtures thereof.
A cosmetic composition according to Claim 9 wherein the volatile silicone oil is selected from cyclic polyorganosiloxanes having viscosities of less than 10 centistokes and linear polyorganosiloxanes having viscosities of less than 5 centistokes at 25°C, and mixtures thereof.
11. A cosmetic composition according to Claim 10 wherein the volatile silicone oil is selected from cyclic polydimethylsiloxanb3 containing from 3 to 9 silicon atoms, preferably containing from 4 to 5 silicon atoms and linear polydimethylsiloxanes containing from 3 to 9 silicon atoms.
12. A cosmetic composition according to Claim 11 wherein the non-volatile silicone oil comprises a polydiorganosiloxane-polyoxyalkylene copolymer containing at least one polydiorganosiloxane segment and at least one polyoxyalkylene segment.
13. A cosmetic composition according to Claim 12 wherein the polydiorganosiloxane-polyoxyalkylene copolymer is dimethicone copolyol.
14. A cosmetic composition according to any of Claims 1 to 13 additionally comprising from 0.1% to 30% by weight of humectant.
A cosmetic composition according to Claim 14 wherein the humectant is selected from glycerine and polyglycerylmethacrylate lubricants having a viscosity of from 300,000-1,100,000cps at 250C, and mixtures thereof.
16. A cosmetic composition according to Claim 15 wherein the humectant is glycerine. I--LII I II
17. A cosmetic composition according to any of Claims 1 to 16 comprising from 0.1% to 5% by weight of anti-acne active.
18. A cosmetic composition according to any of Claims 1 to 17 comprising from 0.1% to 5% by weight of pyrrolidone-based complexing agent.
19. A cosmetic composition according to Claim 9 wherein the silicone oil comprises from 2% to 25%, preferably from 5% to 15% by weight of composition of non-volatile silicones.
A cosmetic comp jsition according to any of Claims 1 to 19 comprising from 5% to L"/o ,y weight of composition of humectant.
21. A cosmetic composition according to any of Claims 1 to 20 additionally comprising from 0.1% to 10% by weight of a cross-linked hydrophobic acrylate or methacrylate copolymer.
22. A cosmetic composition according to Claim 21 wherein the cross-linked to. hydrophobic copolymer is in the form of a lattice and wherein at least one t* 9 active ingredient is dispersed uniformly throughout and entrapped within the copolymer lattice, the active ingredient being selected from skin compatible oils, skin compatible humectants, emollients, moisturising agents and sunscreens.
23. A cosmetic composition according to Claim 22 wherein the active t' ingredient is selected from humectants, preferably glycerine.
24. A cosmetic composition according to any of Claims 1 to 23 additionally o* comprising from 1% to 15% by weight of an emollient which is a natural or synthetic oil selected from mineral, vegetable and animal oils, fats and waxes, fatty acid esters, fatty alcohols, alkylene glycol and polyalkylene glycol ethers and esters, fatty acids and mixtures thereof.
B~L~s81 lbl L L-~r~J LIY- I A cosmetic composition according to Claim 24 wherein the emollient is selected from isopropyl palmitate, isopropyl isostearate, dioctyl maleate, propylene glycol dicaprylate/propylene glycol dicaprate, caprylic triglyceride/capric triglyceride, squalane, mineral oil, cetearylisononanoate and lanolin alcohol, and mixtures thereof.
26. A cosmetic composition according to any of Claims 1 to 25 wherein the oil phase comprises from 0.1% to 10%, preferably from 0.1% to 3% by weight of humectant on a composition basis.
27. A cosmetic composition according to any of Claims 1 to 26 comprising from 30% to 95%, preferably from 40% to 80% by weight of the oil phase, and from 5% to 70%, preferably from 20% to 60% by weight of the water phase.
28. A cosmetic composition according to any of Claims 1 to 27 additionally comprising one or more ultraviolet absorbing agents. DATED this 23rd day of September, 1996. THE PROCTER GAMBLE COMPANY WATERMARK PATENT TRADEMARK ATTORNEYS 290 BURWOOD ROAD HAWTHORN VICTORIA 3122 AUSTRALIA LCG:KR Doc 8 AU7520694.WPC C IC~ lil- I II--I INTERNATIONAL SEARCH REPORT International application No. PCT/US94/08838 A. CLASSIFICATION OF SUBJECT MATTER :A61K 31/695, 31/60, 31/62, 31/19 US CL 514/63, 159, 161, 557 According to International Patent Classification (IPC) or to both national classification and IPC B. FIELDS SEARCHED Minimum documentation searched (classification system followed by classification symbols) U.S. 514/63, 159, 161, 557 Documentation searched other than minimum documentation to the extent that such documents are included in the fields searched NONE Electronic data base consulted during the international search (name of data base and, where practicable, search terms used) APS, CAS-ONLINE C. DOCUMENTS CONSIDERED TO BE RELEVANT Category* Citation of document, with indication, where appropriate, of the relevant passages Relevant to claim No. X US, A, 4,826,681 (JACQUET ET AL) 02 May 1989, see the 1-28 entire document. X US, A, 5,145,685 (CARMODY) 08 September 1992, see the 1-28 entire document. O Further documents are listed in the continuation of Box C, See patent family annex. Special categories of cited documents: later document published after the international filing date or priority date and not in conflict with the application but cited to understand the documentdefining the general state of the art which is not considered principle or theory underlying the invention to be of particular relevance E arier docuentpublhed 0 or at i t document of particular relevance; the claimed invention cannot be ier document publhed on or er the inteaionl iling de conidered novel or cannot be conidered to involve an inventivetep L' document which may throw doubts on priority claim(s) or which is when the document is taken alone cited to stabluh the publicaion dale of uother citation or other cited to estab the blcation date of another cittion or other document of particular relevance; the claimed invention cannot be pecial) co.sidered to involve an inventive step when the document is document referring to an oral disclosure. use, exhibition or other combined with one or more other such documents. such combination mean being obvious to a person skilled in the art document published prior to the international filing date but later than document member of the same patent family the priority date claimed Date of the actual comnletion of the international search I Date of mailing of the international search report SEPTEMBER 1994 Name and mailing address of the ISA/US Commissioner of Patents and Trademarks Box PCT Washington. D.C. 20231 Facsimile No. (703) 305-3230 Form PCT/ISA/210 (second sheet)(July 1992)* 17 0CT1994 ~BP~s
AU75206/94A 1993-08-06 1994-08-05 Cosmetic compositions Ceased AU673623B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9316323 1993-08-06
GB939316323A GB9316323D0 (en) 1993-08-06 1993-08-06 Cosmetic compositions
PCT/US1994/008838 WO1995004537A1 (en) 1993-08-06 1994-08-05 Cosmetic compositions

Publications (2)

Publication Number Publication Date
AU7520694A AU7520694A (en) 1995-02-28
AU673623B2 true AU673623B2 (en) 1996-11-14

Family

ID=10740067

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75206/94A Ceased AU673623B2 (en) 1993-08-06 1994-08-05 Cosmetic compositions

Country Status (9)

Country Link
EP (1) EP0717627A4 (en)
JP (1) JPH09501176A (en)
CN (1) CN1130875A (en)
AU (1) AU673623B2 (en)
CA (1) CA2168425A1 (en)
CZ (1) CZ34796A3 (en)
GB (1) GB9316323D0 (en)
TW (1) TW401306B (en)
WO (1) WO1995004537A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9316322D0 (en) * 1993-08-06 1993-09-22 Procter & Gamble Cosmetic compositions
FR2718022B1 (en) 1994-04-01 1996-04-26 Roussel Uclaf Cosmetic or dermatological compositions and their preparation.
GB9416050D0 (en) * 1994-08-09 1994-09-28 Procter & Gamble Anti-acne cosmetic compositions
US5449519C1 (en) * 1994-08-09 2001-05-01 Revlon Consumer Prod Corp Cosmetic compositions having keratolytic and anti-acne activity
US5547989A (en) * 1994-08-19 1996-08-20 Schering-Plough Healthcare Products, Inc. Compositions for treating corns and calluses
GB2299023B (en) * 1995-03-18 1999-03-31 Procter & Gamble Cosmetic compositions
GB2299022B (en) * 1995-03-18 1999-03-31 Procter & Gamble Cosmetic compositions
JP3487390B2 (en) * 1995-06-01 2004-01-19 株式会社資生堂 Emulsion powder cosmetic
UY24246A1 (en) * 1995-06-06 1996-06-14 Neutrogena Corp TROPIC VEHICLES CONTAINING SOLUBILIZED AND STABILIZED AZELAIC ACID
CN1226820A (en) * 1996-06-27 1999-08-25 普罗克特和甘保尔公司 Cosmetic compositions
JPH10324615A (en) * 1997-05-21 1998-12-08 Pola Chem Ind Inc Discrimination of cosmetic for pollinosis
CA2311128C (en) * 1997-11-19 2008-01-29 Schering Aktiengesellschaft Composition with azelaic acid
SE9801647D0 (en) 1998-05-12 1998-05-12 Interhealth Ab Therapeutic composition
US6495498B2 (en) * 1999-05-27 2002-12-17 Johnson & Johnson Consumer Companies, Inc. Detergent compositions with enhanced depositing, conditioning and softness capabilities
US6200964B1 (en) * 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US6432424B1 (en) 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
US6630175B1 (en) 2000-06-29 2003-10-07 Johnson & Johnson Consumer Companies, Inc. Method of reducing eye irritation
US6372791B1 (en) 2000-06-29 2002-04-16 Johnson & Johnson Consumer Companies, Inc. Method of promoting skin cell metabolism
WO2002028361A2 (en) * 2000-09-29 2002-04-11 Johnson & Johnson Consumer Companies, Inc. Compositions for cleansing skin and treating acne
CN1254232C (en) 2001-09-26 2006-05-03 宝洁公司 Topical compositions containing fluid-absorbent solids and adhesive fluids
WO2003026596A1 (en) * 2001-09-26 2003-04-03 The Procter & Gamble Company Topical compositions containing solid particulates and a silicone resin copolymer fluid
US7223386B2 (en) * 2002-03-11 2007-05-29 Dow Corning Corporation Preparations for topical skin use and treatment
US7122174B2 (en) 2002-09-30 2006-10-17 L'oreal S.A. Compositions comprising at least one silicone compound and at least one amine compound, and methods for using the same
DE102004004969A1 (en) * 2004-01-28 2005-08-18 Beiersdorf Ag UV-light-protective filters are used in reducing microcomedones or (optionally together with hydroxy-acids) in increasing the therapeutic effectiveness in acne treatment
ES2569218T3 (en) 2008-12-17 2016-05-09 Ei, Inc. Acne treatment powder base
CZ2011777A3 (en) * 2011-11-29 2012-10-10 Neofyt Spol. S R.O. Composition for removing warts and coarse skin
CN108553411B (en) 2018-07-25 2020-05-12 成都卓阳生物科技有限公司 Azelaic acid gel and preparation method and application thereof
JP2023535057A (en) 2020-07-21 2023-08-15 ケムボー・エルエルシー Diester cosmetic formulation and its use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147782A (en) * 1976-06-24 1979-04-03 William H. Rorer, Inc. Pharmaceutical detergent composition
FR2479819A1 (en) * 1980-04-04 1981-10-09 Fabre Sa Pierre ZINC RETINOATE, PREPARATION AND TOPICAL COMPOSITIONS CONTAINING THE SAME
LU85789A1 (en) * 1985-02-26 1986-09-02 Oreal USE IN THE THERAPEUTIC AND COSMETIC FIELDS OF AN ANHYDROUS SOLUTION OF HYDROGEN PEROXIDE
KR890001556A (en) * 1987-07-01 1989-03-27 권선주 Pharmaceutical composition
US4906305A (en) * 1988-08-18 1990-03-06 Allegheny Ludlum Corporation Method of making a composite drawn article
US5145685A (en) * 1991-04-08 1992-09-08 Dow Corning Corporation Skin treatment method and composition

Also Published As

Publication number Publication date
AU7520694A (en) 1995-02-28
TW401306B (en) 2000-08-11
CA2168425A1 (en) 1995-02-16
EP0717627A1 (en) 1996-06-26
GB9316323D0 (en) 1993-09-22
WO1995004537A1 (en) 1995-02-16
JPH09501176A (en) 1997-02-04
EP0717627A4 (en) 1997-09-10
CN1130875A (en) 1996-09-11
CZ34796A3 (en) 1996-07-17

Similar Documents

Publication Publication Date Title
AU673623B2 (en) Cosmetic compositions
US5871754A (en) Cosmetic compositions
AU691205B2 (en) Cosmetic make-up compositions
AU704041B2 (en) Cosmetic compositions and processes for manufacture thereof
GB2274585A (en) Make-up compositions for cosmetic use
EP0774950A1 (en) Cosmetic make-up compositions
AU694740B2 (en) Cosmetic compositions
CA2258780A1 (en) Cosmetic compositions
WO1996004894A1 (en) Anti-acne cosmetic compositions
US5976521A (en) Anti-acne cosmetic compositions
GB2275419A (en) Cosmetic composition comprising silicone gum
GB2291804A (en) Cosmetic compositions and processes for manufacture thereof
GB2299022A (en) Anti-acne cosmetic composition
GB2299023A (en) An anti-acne cosmetic composition
AU1850899A (en) Cosmetic make-up compositions

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired